Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Does elevated pathogen-specific IgG mean current active infection?

An elevated pathogen-specific IgG result alone does not establish current active infection.

UnsupportedOctober 14, 20269 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Pathogen-specific IgG commonly persists after prior infection or exposure, so an elevated IgG result alone does not establish current active infection.

laying out figure…
1 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

Pathogen-specific IgG often persists after prior infection or exposure, so it commonly reflects immune history rather than ongoing disease. The mechanism described is continued antibody production by long-lived plasma cells after the acute infection has cleared. Because of this persistence, an isolated elevated IgG result cannot reliably time exposure or confirm that active infection is present.

Verified conclusion

Pathogen-specific IgG is primarily a record of immune exposure rather than a stand-alone marker of active disease. This distinction is especially important when interpreting isolated “elevated” results in older adults, in whom antibody kinetics and clinical presentation may vary.

Persistence and biological basis

  • After infection or antigen exposure, pathogen-specific IgG commonly remains detectable after the acute illness has resolved. Long-lived plasma cells—particularly those maintained in bone-marrow survival niches—continue secreting antibody after antigen clearance.
  • The initial fall in antibody concentration largely reflects loss of short-lived plasmablasts; a later, slower decline is consistent with long-lived plasma-cell maintenance.
  • Persistence varies substantially by pathogen, antigen, host factors, and assay threshold. Reported antiviral-antibody half-lives range from approximately 50 to >200 years; estimated tetanus and diphtheria antibody half-lives are about 11 and 19 years, respectively. In one SARS-CoV-2 cohort, spike-specific IgG remained detectable in 94% at 180 days.

Interpretation for current infection

  • An isolated elevated pathogen-specific IgG result does not establish that infection is currently active. It cannot reliably determine the timing of exposure, whether viable pathogen is present, or whether the pathogen explains current symptoms.
  • For SARS-CoV-2, CDC and IDSA state that antibody testing should not be used to diagnose current infection. Anti-spike IgG may result from vaccination, infection, or both.
  • When active infection is suspected, diagnosis should rely on pathogen-appropriate direct testing—such as NAAT/PCR or antigen testing—interpreted alongside symptoms, timing, and clinical findings. Even NAAT positivity may persist after clinical recovery.

Clinical context

  • Serology can have selected roles: paired acute/convalescent samples demonstrating seroconversion or a substantial titre rise may support recent infection, and IgG avidity may occasionally help estimate timing. These approaches are pathogen- and assay-specific.

Bottom line

  • Persistent IgG commonly reflects prior infection, exposure, or vaccination; isolated elevation is evidence of immune history, not proof of current active infection.

References

  1. Persistence of Virus-Specific Antibody after Depletion of Memory B Cells | Journal of Virology — journals.asm.org ↗
  2. Duration of Humoral Immunity to Common Viral and Vaccine Antigens | NEJM — nejm.org ↗
  3. Overview of Testing for SARS-CoV-2 | COVID-19 - CDC — cdc.gov ↗
  4. IDSA Guidelines on the Diagnosis of COVID-19: Serologic ... — idsociety.org ↗
  5. pmc.ncbi.nlm.nih.gov › articles › PMC4933779Immunoglobulin M for Acute Infection: True or False? - PMC — pmc.ncbi.nlm.nih.gov ↗
  6. Infectious Diseases Society of America Guidelines on the ... — academic.oup.com ↗
  7. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity — pmc.ncbi.nlm.nih.gov ↗
  8. Long-Term B Cell Memory After Infection and Vaccination - PMC — pmc.ncbi.nlm.nih.gov ↗
  9. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans — nature.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesDoes pathogen-specific IgM reflect recent immune recognition while a negative blood PCR still miss prior or tissue-limited infection?→Unsupported7 sourcesDoes IgG/IgA reactivity prove ongoing cancer?→